Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00929435 · ClinicalTrials.gov registry record
Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 30
- Enrollment target
NCT00929435 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 30 participants.
The verdict
NCT00929435 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
One hundred new residents will be recruited prior to the start of residency and followed prospectively for a year. Monthly nasal swabs will be performed to identify colonization with methicillin resistant staphylococcus aureus (MRSA).The proportion of study subjects colonized with MRSA at the end of 1 year will be calculated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00929435
The ClinicalTrials.gov registry entry for NCT00929435 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00929435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00929435 about?
NCT00929435 is a clinical study titled "Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians". One hundred new residents will be recruited prior to the start of residency and followed prospectively for a year. Monthly nasal swabs will be performed to identify colonization with methicillin resistant staphylococcus aureus (MRSA).The proportion of study subjects colonized with MRSA at the end of...
What is the current status of trial NCT00929435?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2009-06. Estimated completion is 2012-01.
Who is sponsoring clinical trial NCT00929435?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.